Related Experiment Video
Updated: Jan 2, 2026

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography
Published on: April 4, 2012
The role of PPARγ in childhood obesity-induced fractures
Matthew R McCann1,2, Anusha Ratneswaran2,3,4
11Sydney Medical School, University of Sydney, Sydney, NSW 2006 Australia.
Insights
Childhood obesity lowers bone density and increases fracture risk. Targeting the PPARγ pathway may reduce fat, improve bone health, and treat obesity-related skeletal issues in children.
Area of Science:
- Pediatric Endocrinology
- Bone Biology
- Metabolic Disorders
Background:
- Global obesity rates are rising, affecting children and leading to musculoskeletal issues.
- Childhood obesity is linked to chronic conditions, including significant skeletal disorders.
- Adiposity impacts bone density, necessitating a deeper understanding of underlying mechanisms.
Purpose of the Study:
- To review the effects of childhood adiposity on bone density.
- To describe slipped capital femoral epiphysis and Blount's disease in obese children.
- To explore the role of PPARγ in adipogenesis and bone remodeling.
Main Methods:
- Analysis of clinical studies on childhood obesity and bone density.
- Review of literature on bone remodeling and cellular mediators of bone growth.
- Examination of the transcriptional factor peroxisome proliferator-activated receptor gamma (PPARγ).
Main Results:
- Childhood obesity is associated with decreased bone density and increased risk of skeletal conditions.
- PPARγ is a key regulator of adipocyte differentiation and influences osteoblast populations.
- Higher PPARγ expression in obesity correlates with increased adipocytes and reduced bone density.
Conclusions:
- Modulating PPARγ signaling can shift mesenchymal stem cells towards osteoblastogenesis, enhancing bone mineral density.
- PPARγ presents a potential therapeutic target for reducing adiposity and increasing bone density in obese children.
- Targeting PPARγ may offer a novel treatment strategy for obesity-induced bone fractures in pediatric populations.
Abstract:
Globally, obesity is on the rise with ~ 30% of the world's population now obese, and childhood obesity is following similar trends. Childhood obesity has been associated with numerous chronic conditions, including musculoskeletal disorders. This review highlights the effects of childhood adiposity on bone density by way of analyzing clinical studies and further describing two severe skeletal conditions, slipped capital femoral epiphysis and Blount's disease. The latter half of this review discusses bone remodeling and cell types that mediate bone growth and strength, including key growth factors and transcription factors that help orchestrate this complex pathology. In particular, the transcriptional factor peroxisome proliferator-activated receptor gamma (PPARγ) is examined as it is a master regulator of adipocyte differentiation in mesenchymal stem cells (MSCs) that can also influence osteoblast populations. Obese individuals are known to have higher levels of PPARγ expression which contributes to their increased adipocyte numbers and decreased bone density. Modulating PPAR*gamma* signaling can have significant effects on adipogenesis, thereby directing MSCs down the osteoblastogenesis pathway and in turn increasing bone mineral density. Lastly, we explore the potential of PPARγ as a druggable target to decrease adiposity, increase bone density, and be a treatment for children with obesity-induced bone fractures.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Osteoclasts in Bone Remodeling
Obesity

